Smith & Nephew SNATS, Inc. Common Stock (NY:SNN)

30.10 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Smith & Nephew SNATS, Inc. Common Stock

< Previous 1 2 3 Next >

Smith & Nephew (NYSE:SNN) Looks Like a Decent Value Stock ↗

October 20, 2026

Via Chartmill

Smith & Nephew (NYSE:SNN) Looks Undervalued on Decent Value Screen ↗

August 28, 2026

Via Chartmill

Smith & Nephew SNATS Q2 Earnings Call Highlights ↗

August 09, 2026

Smith & Nephew SNATS (NYSE:SNN) reported second-quarter underlying revenue growth of 1.6%, below management’s expectations, as continued strength in Sports Medicine and ENT was offset by weakness in...

Via MarketBeat

Topics Earnings World Trade

Smith & Nephew (SNN) Q2 2026 Earnings Call Transcript ↗

August 04, 2026

Nath addresses Orthopaedics gaps and skin substitute headwinds.

Via The Motley Fool

Topics Earnings Economy World Trade

Smith & Nephew plc (NYSE:SNN) Caviar Cruise Screen Analysis ↗

July 01, 2026

Via Chartmill

Smith & Nephew (NYSE:SNN) Qualifies as a Quality Investment Through the Caviar Cruise Screen ↗

April 24, 2026

Via Chartmill

Smith & Nephew PLC (NYSE:SNN) Passes the Caviar Cruise Screen for Quality Investing ↗

April 02, 2026

Via Chartmill

Earnings Scheduled For February 25, 2025 ↗

February 25, 2025

Via Benzinga

Earnings Scheduled For August 3, 2023 ↗

August 03, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.

Via Benzinga

Smith & Nephew PLC (NYSE:SNN): A Value Investment in Medical Devices ↗

November 29, 2025

Smith & Nephew (SNN) is a value investment in medical devices, with strong profitability, accelerating growth, and attractive valuation metrics.

Via Chartmill

Organogenesis Holdings (ORGO) Battles Headwinds: Can This Regenerative Medicine Innovator Stage a Comeback?

October 17, 2025

Canton, MA – Organogenesis Holdings Inc. (NASDAQ: ORGO), a prominent player in the regenerative medicine sector, has recently endured a period of significant stock weakness, leaving investors...

Via MarketMinute

Topics Fraud

Trump Administration Review Targets Medical Supply Chain Vulnerabilities ↗

September 25, 2025

The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—including PPE, consumables, and medical devices—to assess reliance on foreign...

Via Benzinga

Topics Economy Government Supply Chain

What Does the Market Think About Smith & Nephew? ↗

September 03, 2025

Via Benzinga

Sterling Infrastructure Posts Better-Than-Expected Earnings, Joins Lemonade, DigitalOcean Holdings, Lattice Semiconductor And Other Big Stocks Moving Higher On Tuesday ↗

August 05, 2025

Via Benzinga

Top 2 Health Care Stocks You May Want To Dump In Q3 ↗

August 05, 2025

Via Benzinga

Why Palantir Technologies Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket ↗

August 05, 2025

Via Benzinga

This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗

March 12, 2025

Via Benzinga

Xpeng, Li Auto And Nutanix Are Among Top 12 Large-Cap Gainers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio? ↗

March 02, 2025

These large-cap stocks were top performers last week. Heico, Xpeng, Li Auto, Lineage, Erie Indemnity, Lloyds, Unum, FICO, Masimo, Smith & Nephew, AB InBev, and Nutanix all saw significant gains.

Via Benzinga

Estée Lauder, Robinhood, eBay And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

October 31, 2024

Via Benzinga

Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

July 05, 2024

Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family

Via Benzinga

Macy's, Koss And Other Big Stocks Moving Higher On Friday ↗

July 05, 2024

Via Benzinga

Activist Investor Takes Stake In Sports Medicine Player Smith & Nephew, Shares Surge ↗

July 05, 2024

Smith & Nephew shares rise as Cevian Capital acquires a 5% stake, aiming to improve operational performance. The medical tech firm faces challenges with declining market cap and mixed revenue growth.

Via Benzinga

4 Stocks to Watch in the Booming Regenerative Medicine Market

May 20, 2024

4 Stocks to Watch in the Booming Regenerative Medicine Market

Via News Direct

Current Analysis: Smith & Nephew ↗

May 17, 2024

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Over the past year, SNN's share price fell about 9.4% from...

Via Talk Markets

7 Robotic Surgery Stocks to Buy for the Future of Healthcare ↗

March 13, 2024

Discover seven robotic surgery stocks primed for growth as the industry evolves. Unveil opportunities in a market set to double by 2033.

Via InvestorPlace

British MedTech Firm Smith & Nephew Seeks To Adopt US-Inspired Pay Policy to Navigate Shareholder Skepticism ↗

March 12, 2024

Smith & Nephew shakes up executive pay structure, aligning with US standards to curb turnover. Chairman Rupert Soames addresses global talent recruitment challenges and the shift's significance in the...

Via Benzinga

3 Millionaire-Maker Robotics Stocks to Buy in February 2024 ↗

February 21, 2024

Jump into the future with top robotics stocks poised for explosive growth. Discover the potential for massive returns.

Via InvestorPlace

Alphabet To Rally Over 10%? Here Are 10 Other Analyst Forecasts For Wednesday ↗

October 04, 2023

Citigroup raised the price target for LyondellBasell Industries N.V. (NYSE: LYB) from $104 to $106. Citigroup analyst Patrick Cunningham upgraded the stock from Neutral to Buy. LyondellBasell...

Via Benzinga

Smith & Nephew Raises Revenue Growth Outlook After Strong 1H Performance, Sports Medicine and Wound Management Show Strength ↗

August 03, 2023

Smith & Nephew PLC (NYSE: SNN) reported improved revenue, profit, and margin in the

Via Benzinga

AstraZeneca, ECARX Holdings And Other Big Stocks Moving Lower On Monday ↗

July 03, 2023

U.S. stocks traded mixed, with the Dow Jones dropping around 30 points on Monday. Here are some big stocks recording losses in today’s session. Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.